Skip to content

Discontinued — last reported Q1 '26

Total Revenue at other companies

Abbott logo
AbbottABT
$11.16B+7.8%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$24.06B+9.9%
Boston Scientific logo
Boston ScientificBSX
$5.2B+11.6%
Medtronic logo
MedtronicMDT
$9.81B+9.9%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$381.88M+7.5%
ITG
Integer HoldingsITGR
$439.58M+0.5%

Other financials

Income statement

See full
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.8B+38.4%
Enterprise value$1.73B+48.1%
P/S2,391.5×

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s total revenue?
Pulse Biosciences, Inc. (PLSE) reported total revenue of $401K in Q1 2026.
What is the long-term trend for Pulse Biosciences, Inc.'s total revenue?
Over 3 years (2022 to 2025), Pulse Biosciences, Inc.'s total revenue has grown at a -21.0% compound annual growth rate (CAGR), from $709K to $350K.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.